These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 8973418
1. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique. Ang HH, Chan KL, Mak JW. J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418 [Abstract] [Full Text] [Related]
3. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture. Ang HH, Cheang HS, Mak JW. Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695 [Abstract] [Full Text] [Related]
4. In vitro susceptibility studies of Malaysian Plasmodium falciparum isolates and clones against schizontocidal drugs. Ang HH, Chan KL, Mak JW. Folia Parasitol (Praha); 1998 Oct; 45(3):196-8. PubMed ID: 9805783 [Abstract] [Full Text] [Related]
12. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil]. Pradines B, Mabika Mamfoumbi M, Keundjian A, Lebeau C, Fusai T, Owono Medang M, Rogier C, Parzy D, Kombila M. Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596 [Abstract] [Full Text] [Related]
13. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Chen GX, Mueller C, Wendlinger M, Zolg JW. Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892 [Abstract] [Full Text] [Related]
15. Susceptibility of Malaysian Plasmodium falciparum isolates to antimalarial drugs after cryopreservation and 12 months of continuous in vitro culture. Ang HH, Chan KL, Mak JW. Chemotherapy; 1997 Apr; 43(5):311-5. PubMed ID: 9309363 [Abstract] [Full Text] [Related]
16. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q. Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682 [Abstract] [Full Text] [Related]
17. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities. Kamchonwongpaisan S, Quarrell R, Charoensetakul N, Ponsinet R, Vilaivan T, Vanichtanankul J, Tarnchompoo B, Sirawaraporn W, Lowe G, Yuthavong Y. J Med Chem; 2004 Jan 29; 47(3):673-80. PubMed ID: 14736247 [Abstract] [Full Text] [Related]
18. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study. Biswas S. Indian J Malariol; 2001 Jan 29; 38(3-4):76-83. PubMed ID: 12125519 [Abstract] [Full Text] [Related]